← Browse by Condition
Medical Condition

low risk myelodysplastic syndromes

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06670222 Phase 1
Recruiting

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

Enrollment
24 pts
Location
France
Sponsor
Groupe Francophone des Myelody...
View Trial →